New Generic Yasmin Birth Control Drug Approved
A generic version of the birth control pill Yasmin has been launched. Watson Pharmaceuticals, Inc. has received approval from the Food and Drug Administration (FDA) to sell a product called Zarah, a drospirenone and ethinyl estradiol tablet, which is a generic version of Bayer’s Yasmin.
Watson began shipping the new drug on September 7, despite a pending lawsuit brought by Bayer alleging a patent infringement.
Seth A. Katz, a dangerous drug attorney with Burg Simpson is watching these developments closely. “ The introduction of Zarah is a concern. The combination of drospirenone and ethinyl estradiol has been known to cause an increase in potassium levels in the blood, which can lead to a condition known as hyperkalemia. Hyperkalemia can cause heart rhythm disturbances, such as extrasystolies, pauses or bradycardia. If hyperkalemia disrupts the normal heart rhythms, the flow of the blood through the heart can be slowed to the point that it permits blood clots to form. Blood clots in the heart can then lead to heart attacks, or break off and travel to the lungs where they can cause pulmonary embolus, or travel to the brain, causing a stroke.”
Burg Simpson is currently representing more than 1,400 women nationwide who allege that they were seriously injured as a result of taking birth control pills containing drospirenone and ethinyl estradiol. Further information is available by calling toll free 1.888.895.2080
